Jane Street’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,427
Closed -$40K 12901
2025
Q4
$40K Buy
+38,427
New +$67.9K ﹤0.01% 10568
2022
Q2
Sell
-30,009
Closed -$2.96M 10782
2022
Q1
$2.96M Sell
30,009
-1,045
-3% -$103K ﹤0.01% 3986
2021
Q4
$3.06M Buy
31,054
+781
+3% +$77.9K ﹤0.01% 3649
2021
Q3
$3.01M Buy
30,273
+270
+0.9% +$26.6K ﹤0.01% 3649
2021
Q2
$2.98M Buy
+30,003
New +$2.99M ﹤0.01% 3581

Other funds holding SNTI

Jane Street's SNTI Position: Q1 2026 in Review

Jane Street sold out of Senti Biosciences Holdings (SNTI) in Q1 2026, closing a stake of 38,427 shares — an estimated $40K sold.

Jane Street first reported a position in SNTI in Q2 2021 and held it in 5 quarters. The position peaked at $3.06M in Q4 2021. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • Jane Street reported no remaining Senti Biosciences Holdings position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 38,427 Senti Biosciences Holdings shares in Q1 2026, an estimated $40K.
  • Jane Street first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 5 quarters.
  • Jane Street's Senti Biosciences Holdings position peaked at $3.06M in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.